Literature DB >> 22711310

Methodological remarks concerning the recent meta-analysis on CYP1A1 polymorphisms-smoking interaction and hepatocellular carcinoma risk.

Fei Liu, Bo Li, Yong-Gang Wei, Wen-Tao Wang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22711310     DOI： 10.1007/s11033-012-1766-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN： 0301-4851            Impact factor:   2.316


× No keyword cloud information.
  8 in total

1.  Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power.

Authors:  Georgia Salanti; Georgia Amountza; Evangelia E Ntzani; John P A Ioannidis
Journal:  Eur J Hum Genet       Date:  2005-07       Impact factor: 4.246

2.  Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations.

Authors:  Thomas A Trikalinos; Georgia Salanti; Muin J Khoury; John P A Ioannidis
Journal:  Am J Epidemiol       Date:  2006-01-12       Impact factor: 4.897

Review 3.  A century of Hardy-Weinberg equilibrium.

Authors:  Oliver Mayo
Journal:  Twin Res Hum Genet       Date:  2008-06       Impact factor: 1.587

4.  Interactions between CYP1A1 polymorphisms and cigarette smoking are associated with the risk of hepatocellular carcinoma: evidence from epidemiological studies.

Authors:  Lei Yu; Lei Sun; Yang-Fang Jiang; Bao-Ling Lu; De-Rong Sun; Li-Ying Zhu
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

5.  Polymorphisms of estrogen-metabolizing genes and risk of hepatocellular carcinoma in Taiwan females.

Authors:  Pen-Hui Yin; Hsin-Chen Lee; Gar-Yang Chau; Tsung-Yun Liu; Hsiu-Chih Liu; Wing-Yiu Lui; Chin-Wen Chi
Journal:  Cancer Lett       Date:  2004-08-30       Impact factor: 8.679

6.  Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.

Authors:  Takeshi Imaizumi; Yasuki Higaki; Megumi Hara; Tatsuhiko Sakamoto; Mikako Horita; Toshihiko Mizuta; Yuichiro Eguchi; Tsutomu Yasutake; Iwata Ozaki; Kyosuke Yamamoto; Shingo Onohara; Seiji Kawazoe; Hirohisa Shigematsu; Shunzo Koizumi; Sho Kudo; Keitaro Tanaka
Journal:  Carcinogenesis       Date:  2009-07-30       Impact factor: 4.944

7.  CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.

Authors:  Laura Silvestri; Laura Sonzogni; Annalisa De Silvestri; Chiara Gritti; Luciana Foti; Claudio Zavaglia; Michela Leveri; Agostino Cividini; Mario U Mondelli; Emilio Civardi; Enrico M Silini
Journal:  Int J Cancer       Date:  2003-04-10       Impact factor: 7.396

8.  Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma.

Authors:  Xiaoyan Yuan; Gangqiao Zhou; Yun Zhai; Weimin Xie; Ying Cui; Jia Cao; Lianteng Zhi; Hongxing Zhang; Hao Yang; Xiaoai Zhang; Wei Qiu; Yong Peng; Xiumei Zhang; Ling Yu; Xia Xia; Fuchu He
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254
  8 in total
  1 in total

1.  Are CYP1A1 polymorphisms associated with the risk of hepatocellular carcinoma?

Authors:  Tao Wan
Journal:  Mol Biol Rep       Date:  2012-12-29       Impact factor: 2.316
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.